Citius Pharmaceuticals launches cancer drug LYMPHIR following FDA approval

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/31/2026

1. WDAY
2. ESTC
3. MRVL
4. AFRM
5. RBRK
6. S
7. GAP
8. DG
9. ULTA
10. NVDA

Go back to Citius Pharmaceuticals launches cancer drug LYMPHIR following FDA approval
(NASDAQ: CTOR) Delayed: 0.78 -0.01 (1.27%)
Previous Close $0.79    52 Week High $ 
Open $0.80    52 Week Low $ 
Day High $0.80    P/E N/A 
Day Low $0.75    EPS $ 
Volume 21,704       

(NASDAQ: CTXR) Delayed: 0.60 -0.03 (4.76%)
Previous Close $0.63    52 Week High $2.50 
Open $0.62    52 Week Low $0.40 
Day High $0.63    P/E N/A 
Day Low $0.59    EPS $0.00 
Volume 361,733